Trial Details
RECRUITINGBasic Information
| Clinical ID | c1581 |
|---|---|
| Identifier | NCT04846959 |
| Trial Title | Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment |
| Interventions | DRUG: Risankizumab|DRUG: Comparator |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Morrisville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2021-07-30 |
|---|---|
| Primary Completion Date | 2032-06 |
| Completion Date | 2032-06 |